Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy. (Q47096856)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

title

Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

author

Alejandro Villar-Prados

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Brenda Melendez

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

19

Patrick Hwu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

23

Anil K Sood

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

author name string

Yasmin A Lyons

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Sunila Pradeep

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Sherry Y Wu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Monika Haemmerle

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Jean M Hansen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Michael J Wagner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Archana S Nagaraja

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Robert L Dood

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Rebecca A Previs

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Wei Hu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Yang Zhao

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Duncan H Mak

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Zhilan Xiao

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Gregory A Lizee

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Imelda Mercado-Uribe

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Keith A Baggerly

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Jinsong Liu

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Willem W Overwijk

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Robert L Coleman

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

language of work or name

English

0 references

publication date

24 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

page(s)

96496-96505

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

issue

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy.

6 April 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5722500

Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5722500

Trabectedin: Supportive care strategies and safety profile

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5722500

Single-cell mass cytometry reveals intracellular survival/proliferative signaling in FLT3-ITD-mutated AML stem/progenitor cells

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5722500

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5722500

A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5722500

Targeting tumor-infiltrating macrophages to combat cancer

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5722500

Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5722500

Role of the hypoxic tumor microenvironment in the resistance to anti-angiogenic therapies

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5722500

Modes of resistance to anti-angiogenic therapy

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5722500

Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5722500

CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5722500

Incorporation of bevacizumab in the primary treatment of ovarian cancer

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5722500

Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/29228548

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.18632/ONCOTARGET.20410

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29228548%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

1 reference